Ultrasound‐Defined Sarcopenia Independently Predicts Acute Decompensation in Advanced Chronic Liver Disease
Journal of Cachexia, Sarcopenia and Muscle · 2024-12 · 15 (6) · 2792-2802
DOI: 10.1002/jcsm.13630 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 11.11.2024. Verfasst von Juliana Gödiker und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine B, University Hospital Münster, Münster, Germany. Hauptthemen laut MEDLINE: Sarcopenia, Ultrasonography. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Else Kröner-Fresenius-Stiftung, BONFOR Research Program of the University of Bonn, Ernst-und-Berta Grimmke Foundation.
Abstract (Originalsprache)
Background
It has been shown that in patients with liver cirrhosis, sarcopenia is a predictor of acute decompensation (AD), acute‐on‐chronic liver failure (ACLF) and death. However, computer tomography (CT), as a suggested standard method for diagnosing sarcopenia, is resource intensive and involves radiation exposure. Therefore, in this study, we evaluate the muscle thickness of quadriceps femoris measured by ultrasound (US) as a prognostic parameter for AD and all‐cause mortality in chronic liver disease.
Methods
Sixty‐three patients with chronic liver disease and signs of portal hypertension were analysed in this prospective monocentric study for the occurrence of acute decompensation such as hepatic encephalopathy, ascites, haemorrhage and liver‐related death within 1 year. We assessed muscle thickness at three different heights in terms of suitability as a predictor.
Results
Among all 63 patients, 15 patients experienced acute decompensation, and 9 patients died due to liver‐related death. We found the upper third of the muscle, measured without applying pressure with the transducer, to be the most significant for predicting AD/ACLF [AUC 0.739 (confidence interval (CI) 0.604–0.874, p = 0.006]. A cut‐off value of US‐defined muscle thickness standardized per height for identifying sarcopenia was determined (1.83 cm/m). Patients with US‐defined sarcopenia showed significantly higher rates of AD (38.9% vs. 3.7%, p = 0.001) and all‐over 1‐year mortality (27.8% vs. 3.7%, p = 0.013). The mean AD free survival time is 8.3 months (95% CI 6.6–9.9) for sarcopenic patients and 11.8 months (95% CI 11.0–12.6) for the non‐sarcopenic cohorts. Corresponding CT analysis displayed similar results for AD free survival for both groups (40% AD rate in the sarcopenic group vs. 7% AD rate in the non‐sarcopenic group, p = 0.001). The risk for AD was significantly higher in the sarcopenic cohort compared with those without sarcopenia in both US and CT (US: HR 16.6; p = 0.009; 95% CI 2.0–136.0; CT: HR 8.7; p = 0.017; 95% CI 1.5–51.0). CT and US displayed a moderate agreement ( p = 0.006; κ = 0.379).
Conclusions
Sarcopenia classification based on US measurements is shown to be an independent predictor of AD occurrence within 1 year. This pilot study is the first to suggest that screening for sarcopenia by ultrasonography may be useful for risk assessment in patients with chronic liver disease and signs of portal hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine B, University Hospital Münster, Münster, Germany.
- Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
- Center for Cirrhosis and Portal Hypertension Bonn (CCB), University Hospital Bonn, Bonn, Germany.
ORCID-Profile: Juliana Gödiker, Michael Praktiknjo
Förderung
- Else Kröner-Fresenius-Stiftung
- BONFOR Research Program of the University of Bonn
- Ernst-und-Berta Grimmke Foundation
- Deutsche Forschungsgemeinschaft
- Ernst und Berta Grimmke Stiftung
Zitieren
APA
Gödiker, J., Schwind, L., Jacob, T., Böhling, N., Reinartz Groba, S. N., Kimmann, M., Meier, J. A., Peiffer, K. H., Trebicka, J., Chang, J., & Praktiknjo, M. (2024). Ultrasound‐Defined Sarcopenia Independently Predicts Acute Decompensation in Advanced Chronic Liver Disease. Journal of Cachexia, Sarcopenia and Muscle, 15(6), 2792-2802. https://doi.org/10.1002/jcsm.13630
Vancouver
Gödiker J, Schwind L, Jacob T, Böhling N, Reinartz Groba SN, Kimmann M, et al. Ultrasound‐Defined Sarcopenia Independently Predicts Acute Decompensation in Advanced Chronic Liver Disease. Journal of Cachexia, Sarcopenia and Muscle. 2024;15(6):2792-2802. doi:10.1002/jcsm.13630
BibTeX
@article{Gdiker2024,
author = {Gödiker, Juliana and Schwind, Lea and Jacob, Torid and Böhling, Nina and Reinartz Groba, Sara Noemi and Kimmann, Markus and Meier, Jörn Arne and Peiffer, Kai-Henrik and Trebicka, Jonel and Chang, Johannes and Praktiknjo, Michael},
title = {Ultrasound‐Defined Sarcopenia Independently Predicts Acute Decompensation in Advanced Chronic Liver Disease},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2024},
volume = {15},
number = {6},
pages = {2792--2802},
doi = {10.1002/jcsm.13630}
}
EUVIMED